0001127602-24-010323.txt : 20240315
0001127602-24-010323.hdr.sgml : 20240315
20240315190800
ACCESSION NUMBER: 0001127602-24-010323
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240314
FILED AS OF DATE: 20240315
DATE AS OF CHANGE: 20240315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Luput Cristian
CENTRAL INDEX KEY: 0001913350
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41455
FILM NUMBER: 24756465
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAIA Biotechnology, Inc.
CENTRAL INDEX KEY: 0001878313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
BUSINESS PHONE: 312-416-8592
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-03-14
0001878313
MAIA Biotechnology, Inc.
MAIA
0001913350
Luput Cristian
444 WEST LAKE STREET, SUITE 1700
CHICAGO
IL
60606
1
0
Common Stock
2024-03-14
4
P
0
69282
1.17
A
367350
D
Warrants
1.30
2024-03-14
4
P
0
69282
1.30
A
2024-09-14
2029-09-14
Common Stock
69282
69282
D
The common stock was purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024.
The warrants were purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024. The options are exercisable beginning on the six month anniverary of the issuance date and expire 5-years after the initial exercise date.
/s/ Cristian Luput
2024-03-15